Updated:
Ipca Laboratories Limited
Ipca Laboratories operates as a fully-integrated pharmaceutical manufacturer producing both formulations and active pharmaceutical ingredients (APIs).
Ipca Laboratories Limited
Ipca Laboratories operates as a fully-integrated pharmaceutical manufacturer producing both formulations and active pharmaceutical ingredients (APIs). The company's global client list includes AstraZeneca, GlaxoSmithKline, Merck, Roche, and Sanofi Aventis (per firm website, 2025). Its manufacturing footprint and supply chain support distribution to over 120 countries. The company focuses on backward integration to maintain supply-chain reliability and cost competitiveness, positioning itself as one of India's top API exporters. It covers multiple therapeutic segments through its product line of over 350 formulations and 80 APIs. Ipca also invests in research and development, with dedicated R&D infrastructure supporting new product development and regulatory compliance. In September 2025, Ipca reduced product prices to pass on the benefit of a government GST rate cut, reflecting its stated commitment to making healthcare more affordable. The company has maintained operations for over 60 years and supports corporate social responsibility initiatives centered on patient health, employee and public safety, environmental stewardship, and sustainable communities. As a publicly listed entity, Ipca Laboratories is structured as a corporation rather than a family office or investment vehicle. Its primary capital deployment is into manufacturing capacity, R&D, and supply chain infrastructure rather than external investments.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
Mumbai, India
Sector focus
Frequently asked questions
What is Ipca Laboratories' primary business structure?
Ipca Laboratories is a publicly listed corporation, not a family office or investment vehicle. It operates as a fully-integrated pharmaceutical manufacturer with its own manufacturing facilities, R&D infrastructure, and supply chain.
Which major pharmaceutical companies are clients of Ipca?
Ipca counts AstraZeneca, GlaxoSmithKline, Merck, Roche, and Sanofi Aventis among its international client list (per firm website, 2025). These partnerships span multiple therapeutic areas and geographic markets.
How many countries does Ipca supply?
Ipca distributes its products to over 120 countries across six continents. It has been a healthcare partner in these markets for more than 60 years.
Does Ipca manufacture its own active pharmaceutical ingredients (APIs)?
Yes, Ipca manufactures over 80 APIs in addition to more than 350 formulations. It emphasizes backward integration to ensure supply chain reliability and cost competitiveness, which has made it one of India's top API exporters.
What recent pricing action did Ipca take in September 2025?
In September 2025, Ipca reduced prices on its products to pass along the benefit of a government GST rate cut. The company stated this move reflected its commitment to making healthcare more affordable (per firm website, 2025).
Does Ipca maintain a corporate social responsibility program?
Yes, Ipca's CSR initiatives focus on patient health, employee and public safety, environmental nurturing, and building sustainable communities (per firm website, 2025). The company describes these efforts as operating at a micro level within its operational areas.
Is Ipca Laboratories involved in research and development?
Yes, the company maintains dedicated R&D infrastructure supporting new product development and regulatory compliance. Its website includes a separate R&D section, indicating ongoing investment in pharmaceutical innovation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: